Citations for
1EIF4E2, GIGYF2, ZFP36
Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements.
Fu R, Olsen MT, Webb K, Bennett EJ, Lykke-Andersen J.
RNA 22(3):373-82. doi: 10.1261/rna.054833.115. Epub 2016 Jan 13. 2016
2AGO2, GIGYF2
Post-transcriptional gene silencing activity of human GIGYF2.
Kryszke MH, Adjeriou B, Liang F, Chen H, Dautry F.
Biochem Biophys Res Commun 475(3):289-94. doi: 10.1016/j.bbrc.2016.05.022. Epub 2016 May 5. 2016
3GIGYF2, PARK11
The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.
Zhang Y, Sun QY, Yu RH, Guo JF, Tang BS, Yan XX.
Neurol Sci 36(11):2073-9. doi: 10.1007/s10072-015-2316-9. Epub 2015 Jul 8. 2015
4GIGYF2, PARK11
GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment.
Ruiz-Martinez J, Krebs CE, Makarov V, Gorostidi A, Martí-Massó JF, Paisán-Ruiz C.
J Hum Genet 60(10):637-40. doi: 10.1038/jhg.2015.69. Epub 2015 Jul 2. 2015
5GIGYF2
Negative regulation of Grb10 Interacting GYF Protein 2 on insulin-like growth factor-1 receptor signaling pathway caused diabetic mice cognitive impairment.
Xie J, Wei Q, Deng H, Li G, Ma L, Zeng H.
PLoS One 9(9):e108559. doi: 10.1371/journal.pone.0108559. eCollection 2014. 2014
6EIF4E2, GIGYF2
A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development.
Morita M, Ler LW, Fabian MR, Siddiqui N, Mullin M, Henderson VC, Alain T, Fonseca BD, Karashchuk G, Bennett CF, Kabuta T, Higashi S, Larsson O, Topisirovic I, Smith RJ, Gingras AC, Sonenberg N.
Mol Cell Biol 32(17):3585-93. doi: 10.1128/MCB.00455-12. Epub 2012 Jul 2. 2012
7GIGYF2, PARK11
Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
Dos Santos AV, Pestana CP, Diniz KR, Campos M, Abdalla-Carvalho CB, de Rosso AL, Pereira JS, Nicaretta DH, de Carvalho WL, Dos Santos JM, Santos-Rebouças CB, Pimentel MM.
Neurosci Lett 485(2):121-4. doi: 10.1016/j.neulet.2010.08.083. Epub 2010 Sep 17. 2010
8GIGYF2, PARK11
Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.
Tan EK, Lin CH, Tai CH, Tan LC, Chen ML, Li R, Lim HQ, Pavanni R, Yuen Y, Prakash KM, Zhao Y, Wu RM.
Hum Genet 126(3):425-30. Epub 2009 May 16.PMID: 19449032 2009
9GIGYF1, GIGYF2, PARK11
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.
Lautier C, Goldwurm S, DŸrr A, Giovannone B, Tsiaras WG, Pezzoli G, Brice A, Smith RJ.
Am J Hum Genet 82(4):822-33. Epub 2008 Mar 20. 2008
10ABL2, AKAP8, ANKRD13D, AP3D1, ARFGAP3, ARMCX6, ASUN, BAT2L, BCl2L13, BNIP3L, BPTF, BRD7, BZW1, BZW2, C12orf43, C19orf21, C19orf26, C1orf105, C2orf49, C6orf81, CA10, CAD, CARHSP1, CBX4, CCDC55, CCDC61, CCNK, CDC42BPB, CDC42EP3, CDC42EP4, CDS2, CENPN, CLK1, COPA, CSDA, CTPS2, DBN1, DCP1A, DECR2, DPF2, DPM1, EIF2AK1, EPB41L4A, EPN1, FAM91A1, FOSL2, FOXK1, GDF5OS, GFOD2, GIGYF2, GPATCH8, GTPBP1, HES7, HNRNPUL1, KIF1C, LPIN2, LRCH4, MAN2C1, MAST1, MED13, MED24, MED26, MINK1, MYO10, NKTR, OSBP, PAM, PCDH7, PEX14, PHF16, PHRF1, PLCB4, PLXNC1, POM121, POM121L2, PPHLN1, PRICKLE3, PRX, PUM2, RABGGTB, RBEL1, RIMS1, RIMS2, RPL14, RRP1B, RRP8, SAFB, SCAMP3, SCMH1, SCYL1, SENP6, SERBP1, SFRS13A, SFRS17A, SIPA1L1, SLC26A6, SLIRP, SLMAP, SNTA1, SORBS3, SPICE1, SSFA2, STAM, SUB1, TFIP11, TLN2, TMC6, TMEM104, TMEM106B, TMEM22, TOM1, UHRF1, UTP14A, WDR43, ZNF324, ZNF648
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M.
Cell. 127(3):635-48. 2006
11GIGYF2
GYF domain proteomics reveals interaction sites in known and novel target proteins.
Kofler M, Motzny K, Freund C.
Mol Cell Proteomics 4(11):1797-811. Epub 2005 Aug 23. 2005